Literature DB >> 19442935

CO2 activates orexin-containing neurons in mice.

Jinko Sunanaga1, Ben-Shiang Deng, Wei Zhang, Yuichi Kanmura, Tomoyuki Kuwaki.   

Abstract

Accumulating evidence shows possible participation of orexin, a hypothalamic neuropeptide also known as hypocretin, in regulation of breathing. In this study we examined whether hypercapnic stimulation in vivo activates orexin-containing neurons in the hypothalamus. A hypercapnic gas mixture of 10% CO(2), 21% O(2), and residual N(2) or room air was inhaled to awake and freely moving mice for 3h. Their brains were examined by double immunohistochemical staining for orexin and c-Fos. We found that inhalation of CO(2) significantly increased c-Fos expression in the orexin-containing cells that were located in the perifornical region and the dorsomedial hypothalamus (15.8+/-1.6% for room air vs. 28.4+/-2.7% for CO(2), p=0.011) but not in the lateral hypothalamic area (12.3+/-1.2% for room air vs. 12.4+/-3.0% for CO(2)). Although current methodology cannot differentiate between direct effect of CO(2) on the orexin-containing neurons and indirect one through other neurons, this is the first report showing that inhalation of CO(2) did activate the orexin-containing neurons in vivo.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19442935     DOI: 10.1016/j.resp.2009.03.006

Source DB:  PubMed          Journal:  Respir Physiol Neurobiol        ISSN: 1569-9048            Impact factor:   1.931


  35 in total

Review 1.  State-dependent central chemoreception: a role of orexin.

Authors:  Tomoyuki Kuwaki; Aihua Li; Eugene Nattie
Journal:  Respir Physiol Neurobiol       Date:  2010-02-17       Impact factor: 1.931

Review 2.  Central chemoreception in wakefulness and sleep: evidence for a distributed network and a role for orexin.

Authors:  Eugene Nattie; Aihua Li
Journal:  J Appl Physiol (1985)       Date:  2010-02-04

Review 3.  A Decade of Orexin/Hypocretin and Addiction: Where Are We Now?

Authors:  Morgan H James; Stephen V Mahler; David E Moorman; Gary Aston-Jones
Journal:  Curr Top Behav Neurosci       Date:  2017

4.  Effects of chronic sleep fragmentation on wake-active neurons and the hypercapnic arousal response.

Authors:  Yanpeng Li; Lori A Panossian; Jing Zhang; Yan Zhu; Guanxia Zhan; Yu-Ting Chou; Polina Fenik; Seema Bhatnagar; David A Piel; Sheryl G Beck; Sigrid Veasey
Journal:  Sleep       Date:  2014-01-01       Impact factor: 5.849

5.  The orexin receptor 1 (OX1R) in the rostral medullary raphe contributes to the hypercapnic chemoreflex in wakefulness, during the active period of the diurnal cycle.

Authors:  Mirela Barros Dias; Aihua Li; Eugene Nattie
Journal:  Respir Physiol Neurobiol       Date:  2009-12-06       Impact factor: 1.931

6.  Antagonism of rat orexin receptors by almorexant attenuates central chemoreception in wakefulness in the active period of the diurnal cycle.

Authors:  Aihua Li; Eugene Nattie
Journal:  J Physiol       Date:  2010-06-14       Impact factor: 5.182

7.  Dorsal Raphe Serotonin Neurons Mediate CO2-Induced Arousal from Sleep.

Authors:  Haleigh R Smith; Nicole K Leibold; Daniel A Rappoport; Callie M Ginapp; Benton S Purnell; Nicole M Bode; Stephanie L Alberico; Young-Cho Kim; Enrica Audero; Cornelius T Gross; Gordon F Buchanan
Journal:  J Neurosci       Date:  2018-01-29       Impact factor: 6.167

8.  An augmented CO2 chemoreflex and overactive orexin system are linked with hypertension in young and adult spontaneously hypertensive rats.

Authors:  Aihua Li; Sarah H Roy; Eugene E Nattie
Journal:  J Physiol       Date:  2016-05-29       Impact factor: 5.182

9.  OREXIN 1 AND 2 RECEPTOR INVOLVEMENT IN CO2 -INDUCED PANIC-ASSOCIATED BEHAVIOR AND AUTONOMIC RESPONSES.

Authors:  Philip L Johnson; Lauren M Federici; Stephanie D Fitz; John J Renger; Brock Shireman; Christopher J Winrow; Pascal Bonaventure; Anantha Shekhar
Journal:  Depress Anxiety       Date:  2015-08-19       Impact factor: 6.505

Review 10.  Chemoreception and asphyxia-induced arousal.

Authors:  Patrice G Guyenet; Stephen B G Abbott
Journal:  Respir Physiol Neurobiol       Date:  2013-04-19       Impact factor: 1.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.